Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million...
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Financial Highlights
- Tot… [+15690 chars]









